Cancer Research The Future of Cancer Research: Science and Patient Impact  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Peluso, M.
Right arrow Articles by Vineis, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Peluso, M.
Right arrow Articles by Vineis, P.
[Cancer Research 65, 8042-8048, September 1, 2005]
© 2005 American Association for Cancer Research


Epidemiology and Prevention

DNA Adducts and Lung Cancer Risk: A Prospective Study

Marco Peluso1, Armelle Munnia1, Gerard Hoek3, Michal Krzyzanowski5, Fabrizio Veglia6, Luisa Airoldi8, Herman Autrup11, Alison Dunning12, Seymour Garte9, Pierre Hainaut14, Christian Malaveille14, Emmanuelle Gormally14, Giuseppe Matullo6, Kim Overvad15, Ole Raaschou-Nielsen16, Francoise Clavel-Chapelon17, Jacob Linseisen18, Heiner Boeing19, Antonia Trichopoulou20, Dimitrios Trichopoulos20, Anna Kaladidi20, Domenico Palli2, Vittorio Krogh10, Rosario Tumino21, Salvatore Panico22, H. Bas Bueno-De-Mesquita23, Petra H. Peeters4, Merethe Kumle24, Carlos A. Gonzalez25, Carmen Martinez26, Miren Dorronsoro27, Aurelio Barricarte28, Carmen Navarro29, J. Ramón Quiros30, Goran Berglund31, Lars Janzon31, Bengt Jarvholm32, Nicholas E. Day13, Tim J. Key33, Rodolfo Saracci14, Rudolf Kaaks14, Elio Riboli14 and Paolo Vineis7,34

1 Cancer Risk Factor Branch and 2 Molecular and Nutritional Epidemiology Unit, CSPO-Scientific Institute of Tuscany Region, Florence, Italy; 3 Department of Environmental and Occupational Health, Utrecht University; 4 Julius Center for Health Sciences and Primary Care, University Medical Center, Utrecht, the Netherlands; 5 WHO, European Centre for Environment and Health, Bonn, Germany; 6 ISI Foundation; 7 University of Turin, Turin, Italy; 8 Istituto Mario Negri; 9 Genetics Research Institute; 10 Department of Epidemiology, National Cancer Institute, Milan, Italy; 11 Department of Environmental and Occupational Medicine, Aarhus, Denmark; 12 Department of Oncology, University of Cambridge; 13 Medical Research Council Dunn Human Nutrition Unit, Cambridge, United Kingdom; 14 IARC, Lyon, France; 15 Department of Clinical Epidemiology, Aalborg Hospital, Aarhus University Hospital, Aalborg, Denmark; 16 Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark; 17 Institut National de la Sante et de la Recherche Medicale U521, Institut Gustave Roussy, Villejuif, France; 18 Division of Clinical Epidemiology, Deutsches Krebsforschungszentrum, Heidelberg, Germany; 19 German Institute of Human Nutrition, Potsdam-Rehbücke, Germany; 20 Department of Hygiene and Epidemiology, Medical School, University of Athens, Athens, Greece; 21 Cancer Registry, Azienda Ospedaliera "Civile MP Arezzo," Ragusa, Italy; 22 Dipartimento di Medicina Clinica e Sperimentale, Università Federico II, Naples, Italy; 23 Centre for Nutrition and Health, National Institute for Public Health and the Environment, Bilthoven, the Netherlands; 24 Institute of Community Medicine, University of Tromso, Tromso, Norway; 25 Department of Epidemiology, Catalan Institute of Oncology, Barcelona, Spain; 26 Andalusian School of Public Health, Granada, Spain; 27 Department of Public Health of Guipuzkoa, San Sebastian, Spain; 28 Public Health Institute, Navarra, Spain; 29 Epidemiology Department, Murcia Health Council, Murcia, Spain; 30 Dirección General de Salud Pública, Consejería de Salud y Servicios Sanitarios Asturias, Oviedo, Spain; 31 Malmö Diet and Cancer Study, Lund University, Malmö, Sweden; 32 Department of Nutritional Research, University of Umeå, Umeå, Sweden; 33 Cancer Research UK Epidemiology Unit, University of Oxford, Oxford, United Kingdom; and 34 Imperial College London, London, United Kingdom

Requests for reprints: Marco Peluso, Cancer Risk Factor Branch, CSPO-Scientific Institute of Tuscany Region, Villa Delle Rose, Via Cosimo il Vecchio N. 2, Florence, Italy 50139. Phone: 39-55-32-697867; Fax: 39-55-32-6978; E-mail: m.peluso{at}cspo.it.

Objectives were to investigate prospectively the ability of DNA adducts to predict cancer and to study the determinants of adducts, especially air pollutants. DNA adducts were measured in a case-control study nested in the European Prospective Investigation into Cancer and Nutrition (EPIC) investigation. Cases included newly diagnosed lung cancer (n = 115), upper respiratory cancers (pharynx and larynx; n = 82), bladder cancer (n = 124), leukemia (n = 166), and chronic obstructive pulmonary disease or emphysema deaths (n = 77) accrued after a median follow-up of 7 years among the EPIC former smokers and never-smokers. Three controls per case were matched for questionnaire analyses and two controls per case for laboratory analyses. Matching criteria were gender, age, smoking status, country of recruitment, and follow-up time. Individual exposure to air pollution was assessed using concentration data from monitoring stations in routine air quality monitoring networks. Leukocyte DNA adducts were analyzed blindly using 32P postlabeling technique. Adducts were associated with the subsequent risk of lung cancer, with an odds ratio (OR) of 1.86 [95% confidence interval (95% CI), 0.88-3.93] when comparing detectable versus nondetectable adducts. The association with lung cancer was stronger in never-smokers (OR, 4.04; 95% CI, 1.06-15.42) and among the younger age groups. After exclusion of the cancers occurring in the first 36 months of follow-up, the OR was 4.16 (95% CI, 1.24-13.88). A positive association was found between DNA adducts and ozone (O3) concentration. Our prospective study suggests that leukocyte DNA adducts may predict lung cancer risk of never-smokers. Besides, the association of DNA adduct levels with O3 indicates a possible role for photochemical smog in determining DNA damage.




This article has been cited by other articles:


Home page
CarcinogenesisHome page
F. Veglia, S. Loft, G. Matullo, M. Peluso, A. Munnia, F. Perera, D. H. Phillips, D. Tang, H. Autrup, O. Raaschou-Nielsen, et al.
DNA adducts and cancer risk in prospective studies: a pooled analysis and a meta-analysis
Carcinogenesis, May 1, 2008; 29(5): 932 - 936.
[Abstract] [Full Text] [PDF]


Home page
aacredbookHome page
P. Vineis and F. Perera
Molecular Epidemiology and Biomarkers in Etiologic Cancer Research: The New in Light of the Old
Am. Assoc. Cancer Res. Educ. Book, April 12, 2008; 2008(1): 547 - 567.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
B. A. Rybicki, C. Neslund-Dudas, C. H. Bock, A. Rundle, A. T. Savera, J. J. Yang, N. L. Nock, and D. Tang
Polycyclic Aromatic Hydrocarbon-DNA Adducts in Prostate and Biochemical Recurrence after Prostatectomy
Clin. Cancer Res., February 1, 2008; 14(3): 750 - 757.
[Abstract] [Full Text] [PDF]


Home page
MutagenesisHome page
A. Munnia, F. Saletta, A. Allione, S. Piro, M. Confortini, G. Matullo, and M. Peluso
32P-Post-labelling method improvements for aromatic compound-related molecular epidemiology studies
Mutagenesis, November 1, 2007; 22(6): 381 - 385.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
P. Vineis and F. Perera
Molecular Epidemiology and Biomarkers in Etiologic Cancer Research: The New in Light of the Old
Cancer Epidemiol. Biomarkers Prev., October 1, 2007; 16(10): 1954 - 1965.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
G. Castano-Vinyals, G. Talaska, N. Rothman, J. Alguacil, M. Garcia-Closas, M. Dosemeci, K. P. Cantor, N. Malats, F. X. Real, D. Silverman, et al.
Bulky DNA Adduct Formation and Risk of Bladder Cancer
Cancer Epidemiol. Biomarkers Prev., October 1, 2007; 16(10): 2155 - 2159.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
P Vineis, F Veglia, S Garte, C Malaveille, G Matullo, A Dunning, M Peluso, L Airoldi, K Overvad, O Raaschou-Nielsen, et al.
Genetic susceptibility according to three metabolic pathways in cancers of the lung and bladder and in myeloid leukemias in nonsmokers
Ann. Onc., July 1, 2007; 18(7): 1230 - 1242.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
J. Tuntawiroon, C. Mahidol, P. Navasumrit, H. Autrup, and M. Ruchirawat
Increased health risk in Bangkok children exposed to polycyclic aromatic hydrocarbons from traffic-related sources
Carcinogenesis, April 1, 2007; 28(4): 816 - 822.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. Manuguerra, G. Matullo, F. Veglia, H. Autrup, A.M. Dunning, S. Garte, E. Gormally, C. Malaveille, S. Guarrera, S. Polidoro, et al.
Multi-factor dimensionality reduction applied to a large prospective investigation on gene-gene and gene-environment interactions
Carcinogenesis, February 1, 2007; 28(2): 414 - 422.
[Abstract] [Full Text] [PDF]


Home page
MutagenesisHome page
V. M. Arlt, E. Frei, and H. H. Schmeiser
ECNIS-sponsored workshop on biomarkers of exposure and cancer risk: DNA damage and DNA adduct detection and 6th GUM-32P-postlabelling workshop, German Cancer Research Center, Heidelberg, Germany, 29-30 September 2006
Mutagenesis, January 1, 2007; 22(1): 83 - 88.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. Huang, M. R. Spitz, J. Gu, J.J. Lee, J. Lin, S. M.Lippman, and X. Wu
Cyclin D1 gene polymorphism as a risk factor for oral premalignant lesions
Carcinogenesis, October 1, 2006; 27(10): 2034 - 2037.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. Gormally, P. Vineis, G. Matullo, F. Veglia, E. Caboux, E. Le Roux, M. Peluso, S. Garte, S. Guarrera, A. Munnia, et al.
TP53 and KRAS2 Mutations in Plasma DNA of Healthy Subjects and Subsequent Cancer Occurrence: A Prospective Study.
Cancer Res., July 1, 2006; 66(13): 6871 - 6876.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
H. B. Ketelslegers, R. W.H. Gottschalk, R. W.L. Godschalk, A. M. Knaapen, F. J. van Schooten, R. F.M.H. Vlietinck, J. C.S. Kleinjans, and J. H.M. van Delft
Interindividual variations in DNA adduct levels assessed by analysis of multiple genetic polymorphisms in smokers.
Cancer Epidemiol. Biomarkers Prev., April 1, 2006; 15(4): 624 - 629.
[Abstract] [Full Text] [PDF]


Home page
Occup. Environ. Med.Home page
D M DeMarini and L D Claxton
Outdoor air pollution and DNA damage.
Occup. Environ. Med., April 1, 2006; 63(4): 227 - 229.
[Full Text] [PDF]


Home page
CarcinogenesisHome page
P. Vineis and K. Husgafvel-Pursiainen
Air pollution and cancer: biomarker studies in human populations
Carcinogenesis, November 1, 2005; 26(11): 1846 - 1855.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.